GL Biochem (Shanghai) Ltd

GL Biochem (Shanghai) Ltd

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 21-61263452
Mobile: 13641803416
E-mail:
QQ:
Skype: Chat Now!
Company Name:Shanghai GL Peptide Ltd
Tel:86-21-61263385
Fax:86-21-61263399
Email:ymbetter@glbiochem
WebSite:http://www.glbiochem.com
Nationality:CHINA
Product Name MF CAS Details
Histine-Rich Basic Peptide (HRBP)(Aplysia californica) Details
Histone H1-derived peptide??;GGGPATPKKAKKL Details
Histone H3 (1-25),amide,??;ARTKQTARKSTGGKAPRKQLATKAA-NH2 Details
HIV: gp120: 318-327 C48H80N16O12 147841-68-7 Details
HIV Peptide gp120 (254-274) C95H162N28O30S 113944-46-0 Details
Histone H3 (116–136), N15–39??;APRKQLATKAARKSAPATGGVKKPH Details
HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) C44H79N11O14S2 334731-59-8 Details
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) Details
HIV Substrate;KARVNleF(4-NO2)EANle-NH2 C49H83N15O13 128340-47-6 Details
HIV-1 gag Protein p24 (137-154) C92H158N26O26S Details
HIV-1 gag Protein p24 (194-210) C73H126N20O23S 141281-67-6 Details
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22) C73H126N26O18 114991-28-5 Details
HIV (gp120) Antigenic Peptide C117H211N41O31S 198636-94-1 Details
HIV QK10??;QVPLRMTYK Details
Hylambatin C63H90N16O19S2 80890-46-6 Details
Hydrin 1' C51H81N17O15S2 148440-73-7 Details
HOE 140 C59H89N19O13S 130308-48-4 Details
HIV-1 tat Protein (49-57) C53H106N30O11 123251-89-8 Details
HIV (gp41) Fragment C21H38N6O7 129426-47-7 Details
HIV (gp120) Fragment (308-331) C114H199N41O31 115416-08-5 Details
HIV-1, HIV-2 Protease Substrate;ATLNFPISPW C56H80N12O14 Details
HIV-1 Tat (49-57) N-term Cys Details
HIV (gp41) Antigenic Peptide 5 Details
HPV-E6-N Details
Human CMV Assemblin Protease Substrate (M-site) C52H96N20O16 Details
CEF20, Cytomegalovirus, CMV pp65 (495-503);NLVPMVATV C42H74N10O12S 153045-21-7 Details
HLA-DQA1 (62 to 77) Details
Hypercalcemia Malignancy Factor (1-34), amide, human C180H288N58O47 112955-31-4 Details
Human Papillomavirus E7 protein (49-57);RAHYNIVTF C52H77N15O13 Details
Hydrin 2 C45H69N15O14S2 122842-55-1 Details
H-DL-Ala-DL-Phe-OH C12H16N2O3 1999-45-7 Details
H-D-Ala-Gln-octadecyl ester · HCl C18H36ClN3O4 153508-74-8 Details
H-D-Ala-Pro-OH C8H14N2O3 61430-12-4 Details
IL-1 b Converting Enzyme: ICE Substrate II Details
H-DL-Ala-DL-Met-OH C8H16N2O3S 1999-43-5 Details
IL-8ra (9-29) C112H150N24O38S2 188689-66-9 Details
IL-8 (-5 to +5) C48H86N14O14 Details
H-D-Ile-Asp-OH C10H18N2O5 120067-35-8 Details
H-D-Glu(Gly-OH)-OH C7H12N2O5 6729-55-1 Details
Hypocretin (70-98) (human) C125H214N44O37S 1129545-33-0 Details
H-Glu(Trp-OH)-OH C16H19N3O5 66471-20-3 Details
Hypercalcemia Malignancy Factor (1-40);AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATS C207H334N66O58 120298-73-9 Details
H-D-Arg-Gly-Asp-Trp-OH C23H32N8O7 Details
H-DL-Ala-DL-Leu-Gly-OH C11H21N3O4 82267-71-8 Details
IGF-I Analog C55H88N14O15S2 147819-32-7 Details
H-D-Ile-Phe-Lys-pNA C27H38N6O5 76626-41-0 Details
Influenza A NP (366-374)??;ASNEMNDAM C36H59N11O17S2 Details
H-D-Ala-Leu-Lys-AMC C25H37N5O5 104881-72-3 Details
H-DL-Ala-DL-Val-OH C8H16N2O3 1999-46-8 Details
H-D-Ala-Gly-OH C5H10N2O3 3997-90-8 Details
H-DL-Ala-DL-Leu-OH C9H18N2O3 1999-42-4 Details
H-D-Ala-Gln-OH C8H15N3O4 205252-36-4 Details
H-D-Arg-Phe-OH C15H23N5O3 133410-92-1 Details
H-D-Ala-Gly-Gly-OH C7H13N3O4 77286-90-9 Details
H-DL-Ala-DL-Ala-OH C6H12N2O3 2867-20-1 Details
Hypercalcemia Malignancy Factor (1-34), (PLP) human;AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA C180H287N57O48 112540-82-6 Details
Insulin-Like Growth Factor I (30-41) C51H83N19O19 82177-09-1 Details
ig Endothelin-3: 1-41, amide, rat Details
IL-8 Inhibitor C45H66N18O7S 138559-60-1 Details
ICE Inhibitor III Details
H-D-Glu-D-Glu-OH C10H16N2O7 6729-94-8 Details
H-D-Ala-Phe-OH C12H16N2O3 3061-95-8 Details
H-D-Met-Met-OH C10H20N2O3S2 89680-17-1 Details
Hepatitis Virus C NS3 Protease Inhibitor 1 Details
H-D-Phe-Pro-OH C14H18N2O3 51926-52-4 Details
H-D-Leu-Tyr-OH C15H22N2O4 3303-29-5 Details
H-D-Phe-Ala-OH C12H16N2O3 80924-58-9 Details
H-DL-Leu-Gly-DL-Phe-OH C17H25N3O4 4294-25-1 Details
H-DL-Ala-Gly-Gly-OH C7H13N3O4 927-21-9 Details
H-D-Phe-Pro-Arg-chloromethylketone C21H31ClN6O3 71142-71-7 Details
H-D-Leu-Gly-Gly-OH C10H19N3O4 18625-22-4 Details
H-D-Trp-D-Met-p-chloro-D-Phe-Gla-NH2 C31H37ClN6O8S 178396-45-7 Details
Head Activator;Pyr-PPGGSKVILF C54H84N12O14 Details
Hepatitis A Virus (HAV) 3C Protease Substrate C65H87N17O16S 145682-87-7 Details
Hirudin (54-65) (desulfated) C66H93N13O25 113274-56-9 Details
Hemokinin 1 (mouse, rat) C61H100N22O15S 208041-90-1 Details
H-D-Phe-Homopro-Arg-pNA · 2 acetate C31H44N8O9 386253-60-7 Details
Histatin-3 (H3);DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN Details
H-DL-Ala-Gly-OH C5H10N2O3 1188-01-8 Details
H-DL-Leu-Gly-Gly-OH C10H19N3O4 4337-37-5 Details
H-DL-Leu-DL-Ala-OH C9H18N2O3 5060-46-8 Details
H-DL-Val-Leu-Arg-pNA C23H38N8O5 117961-22-5 Details
H-D-Leu-Thr-Arg-pNA C22H36N8O6 122630-72-2 Details
H-D-Phg-Leu-OH C14H20N2O3 110207-44-8 Details
H-DL-Leu-DL-Tyr-OH C15H22N2O4 19659-00-8 Details
H-DL-Leu-Gly-OH C8H16N2O3 615-82-7 Details
H-D-Leu-Gly-OH C8H16N2O3 997-05-7 Details
H-DL-Leu-DL-Phe-OH C15H22N2O3 56217-82-4 Details
H-D-Pro-Phe-Arg-pNA · 2 HCl C26H36Cl2N8O5 62354-56-7 Details
H-D-Leu-D-Leu-OH C12H24N2O3 38689-30-4 Details
H-D-Met-Met-Met-OH C15H29N3O4S3 319927-24-7 Details
Hemoglobin (Hb) (64-76);GKKVITAFNEGLK C64H109N17O18 Details
H-D-Met-D-Met-OH C10H20N2O3S2 89680-20-6 Details
Histatin-5;DSHAKRHHGYKRKFHEKHHSHRGY C133H195N51O33 104339-66-4 Details
H-D-Phe-Ser(Bzl)-Phe-OH C28H31N3O5 Details
H-D-Phe-D-Phe-OH C18H20N2O3 58607-69-5 Details
H-D-Phe-Pro-Arg-5-amido-isophthalic acid-dimethyl ester Details
Hepcidin-25 (human) C113H178N34O31S9 342790-21-0 Details
H-D-Phe-Ser(Bzl)-Phe-Phe-Ala-Ala-4-Abz-OH C53H60N8O10 Details
H-D-Leu-Leu-OH C12H24N2O3 38689-31-5 Details
Product Total: Product Page:
25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100